Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 May 23, 2018 TH Announces Agreement with AIDS DRUG ASSITANCE PROGRAM (ADAP) for TROGARZO™ and EGRIFTA® May 16, 2018 TH Provides Update on Trogarzo™ Prescriptions and Reimbursement Status May 16, 2018 Announcements in Conjunction with TH Annual Meeting May 11, 2018 TH Announces that National Institute of Health will Support Study of EGRIFTA® in Non-HIV Patients with Non-Alcoholic Fatty Liver Disease May 01, 2018 FDA RELEASES THERATECHNOLOGIES FROM POST-APPROVAL COMMITMENTS RELATED TO EGRIFTA® (TESAMORELIN FOR INJECTION) Apr 30, 2018 THERATECHNOLOGIES’ CEO AND CFO TO ATTEND BLOOM BURTON HEALTHCARE INVESTOR CONFERENCE IN TORONTO Apr 30, 2018 THERATECHNOLOGIES ANNOUNCES THAT TROGARZO™ (IBALIZUMAB-UIYK) INJECTION IS NOW AVAILABLE IN THE U.S. Apr 24, 2018 Theratechnologies to Seek Regulatory Approval of Trogarzo™ in Europe Apr 05, 2018 Theratechnologies Announces Financial Results for First Quarter of 2018 Mar 29, 2018 Theratechnologies to Announce Financial Results for First Quarter 2018 First page « Previous page ‹ … Page 21 Page 22 Page 23 Page 24 Current page 25 Page 26 Page 27 Page 28 Page 29 … Next page › Last page » Displaying 241 - 250 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
May 23, 2018 TH Announces Agreement with AIDS DRUG ASSITANCE PROGRAM (ADAP) for TROGARZO™ and EGRIFTA®
May 11, 2018 TH Announces that National Institute of Health will Support Study of EGRIFTA® in Non-HIV Patients with Non-Alcoholic Fatty Liver Disease
May 01, 2018 FDA RELEASES THERATECHNOLOGIES FROM POST-APPROVAL COMMITMENTS RELATED TO EGRIFTA® (TESAMORELIN FOR INJECTION)
Apr 30, 2018 THERATECHNOLOGIES’ CEO AND CFO TO ATTEND BLOOM BURTON HEALTHCARE INVESTOR CONFERENCE IN TORONTO
Apr 30, 2018 THERATECHNOLOGIES ANNOUNCES THAT TROGARZO™ (IBALIZUMAB-UIYK) INJECTION IS NOW AVAILABLE IN THE U.S.